A core outcome set for studies of gestational diabetes mellitus prevention and treatment
Open Access
- 20 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 63 (6), 1120-1127
- https://doi.org/10.1007/s00125-020-05123-6
Abstract
Aims/hypothesis The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). Methods We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised. Results Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). Conclusions/interpretation This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. Trial registration This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/studies/details/686/Funding Information
- University Medical Center Rotterdam
This publication has 27 references indexed in Scilit:
- The CROWN Initiative: journal editors invite researchers to develop core outcomes in women’s healthAmerican Journal of Obstetrics and Gynecology, 2014
- MOMENT – Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyTrials, 2013
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteriaDiabetologia, 2011
- Birth Weight, Family History of Diabetes, and Metabolic Syndrome in Children and AdolescentsThe Journal of Pediatrics, 2010
- Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003Diabetic Medicine, 2010
- Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2010
- Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysisThe Lancet, 2009
- Birth Weight and Risk of Type 2 DiabetesJAMA, 2008
- Hyperglycemia and Adverse Pregnancy OutcomesThe New England Journal of Medicine, 2008